1.22 (1.65%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Website
Ionis Pharmaceuticals, Inc.
Telephone
1.760.931.9200
Address
2855 Gazelle Court, Carlsbad, CA 92010
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 32 - 86.74
Trade Value (12mth)
US$36,486,255.00
1 week
-0.53%
1 month
-1.26%
YTD
-7.32%
1 year
120.42%
All time high
86.74
EPS 3 yr Growth
25.30%
EBITDA Margin
-38.00%
Operating Cashflow
-$269m
Free Cash Flow Return
-10.40%
ROIC
-14.70%
Interest Coverage
-4.00
Quick Ratio
3.80
Shares Outstanding (Fully Diluted)
165m
HALO Sector
Healthcare
Next Company Report Date
24-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 30 April 26 | |
| 29 April 26 | |
| 29 April 26 | |
| 21 April 26 | |
| 21 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.56 | -3.04 | -2.38 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.56 | -3.04 | -2.38 | | | | ||
Growth | % | | | | | -34.5 | -18.7 | 21.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
